von Wagner M - Search Results

1

Effect of ribavirin on virus load and quasispecies distribution in patients infected with hepatitis C virus.

Lee JH, von Wagner M, Roth WK, Teuber G, Sarrazin C, Zeuzem S. Lee JH, et al. Among authors: von wagner m. J Hepatol. 1998 Jul;29(1):29-35. doi: 10.1016/s0168-8278(98)80175-x. J Hepatol. 1998. PMID: 9696489

2

Association of serum interleukin-8 with virologic response to antiviral therapy in patients with chronic hepatitis C.

Mihm U, Herrmann E, Sarrazin U, von Wagner M, Kronenberger B, Zeuzem S, Sarrazin C. Mihm U, et al. Among authors: von wagner m. J Hepatol. 2004 May;40(5):845-52. doi: 10.1016/j.jhep.2004.01.007. J Hepatol. 2004. PMID: 15094234

3

Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection.

von Wagner M, Hofmann WP, Teuber G, Berg T, Goeser T, Spengler U, Hinrichsen H, Weidenbach H, Gerken G, Manns M, Buggisch P, Herrmann E, Zeuzem S. von Wagner M, et al. Hepatology. 2008 Nov;48(5):1404-11. doi: 10.1002/hep.22483. Hepatology. 2008. PMID: 18846541 Clinical Trial.

4

Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirin.

Lange CM, von Wagner M, Bojunga J, Berg T, Farnik H, Hassler A, Sarrazin C, Herrmann E, Zeuzem S. Lange CM, et al. Among authors: von wagner m. Eur J Gastroenterol Hepatol. 2010 Nov;22(11):1303-7. doi: 10.1097/MEG.0b013e32833de92c. Eur J Gastroenterol Hepatol. 2010. PMID: 20729742 Clinical Trial.

5

Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.

Lange CM, Bojunga J, Ramos-Lopez E, von Wagner M, Hassler A, Vermehren J, Herrmann E, Badenhoop K, Zeuzem S, Sarrazin C. Lange CM, et al. Among authors: von wagner m. J Hepatol. 2011 May;54(5):887-93. doi: 10.1016/j.jhep.2010.08.036. Epub 2011 Jan 20. J Hepatol. 2011. PMID: 21145801

6

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover.

Zeuzem S, Schmidt JM, Lee JH, von Wagner M, Teuber G, Roth WK. Zeuzem S, et al. Among authors: von wagner m. Hepatology. 1998 Jul;28(1):245-52. doi: 10.1002/hep.510280132. Hepatology. 1998. PMID: 9657119 Clinical Trial.

7

Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virus.

Lee JH, Teuber G, von Wagner M, Roth WK, Zeuzem S. Lee JH, et al. Among authors: von wagner m. J Med Virol. 2000 Mar;60(3):264-8. J Med Virol. 2000. PMID: 10630957 Clinical Trial.

8

Dynamics of hepatitis C virus quasispecies turnover during interferon-alpha treatment.

von Wagner M, Lee JH, Rüster B, Kronenberger B, Sarrazin C, Roth WK, Zeuzem S. von Wagner M, et al. J Viral Hepat. 2003 Nov;10(6):413-22. doi: 10.1046/j.1365-2893.2003.00457.x. J Viral Hepat. 2003. PMID: 14633173

9

Prospective study of bone mineral density and metabolism in patients with chronic hepatitis C during pegylated interferon alpha and ribavirin therapy.

Hofmann WP, Kronenberger B, Bojunga J, Stamm B, Herrmann E, Bücker A, Mihm U, von Wagner M, Zeuzem S, Sarrazin C. Hofmann WP, et al. Among authors: von wagner m. J Viral Hepat. 2008 Nov;15(11):790-6. doi: 10.1111/j.1365-2893.2008.01038.x. Epub 2008 Jul 28. J Viral Hepat. 2008. PMID: 18673425

10

Viral kinetics during antiviral therapy in patients with chronic hepatitis C and persistently normal ALT levels.

Kronenberger B, Herrmann E, Micol F, von Wagner M, Zeuzem S. Kronenberger B, et al. Among authors: von wagner m. Hepatology. 2004 Dec;40(6):1442-9. doi: 10.1002/hep.20487. Hepatology. 2004. PMID: 15565603 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters